Search Results - "Russell, S N"

Vascular Damage as an Underlying Mechanism of Cardiac and Cerebral Toxicity in Irradiated Cancer Patients by Stewart, F. A., Hoving, S., Russell, N. S.

“…Radiation is an independent risk factor for cardiovascular and cerebrovascular disease in cancer patients. Modern radiotherapy techniques reduce the volume of…”
Get full text

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial by Raphael Daniela, D. B., Russell, N. S., van Werkhoven, E., Immink, J. M., Westhoff, D. P. G., Stenfert Kroese, M. C., Stam, M. R., van Maurik, L. M., van Gestel, C. M. J., van der Weijden, T., Boersma, L. J.

“…Purpose Patient decision aids (PtDAs) have been reported to have a positive influence on patients making a health care decision in trials. Nevertheless,…”
Get full text

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy by Straver, M. E., Rutgers, E. J. Th, Rodenhuis, S., Linn, S. C., Loo, C. E., Wesseling, J., Russell, N. S., Oldenburg, H. S. A., Antonini, N., Vrancken Peeters, M. T. F. D.

“…Background Breast cancer is increasingly considered a heterogeneous disease. The aim of this study was to assess the differences between histological and…”
Get full text

Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design by Russell, N. S., van Werkhoven, E., Schagen, S. B.

“…Purpose Skin toxicity is a common effect from radiotherapy, although difficult to predict on an individual basis, and there is little evidence-based…”
Get full text

Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin’s Disease by van Leeuwen, Flora E., Klokman, Willem J., Stovall, Marilyn, Dahler, Ellen C., van’t Veer, Mars B., Noordijk, Evert M., Crommelin, Mariad A., Aleman, Berthe M. P., Broeks, Annegien, Gospodarowicz, Mary, Travis, Lois B., Russell, Nicola S.

“…Background: Female survivors of Hodgkin’s disease (HD) have a strongly elevated risk of breast cancer, but factors responsible for the increased risk are not…”
Get full text

The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors by Heideman, W.H, Russell, N.S, Gundy, C, Rookus, M.A, Voskuil, D.W

“…Abstract To evaluate the association between systemic treatments and post-diagnosis weight gain in breast cancer patients during longer follow-up periods, we…”
Get full text

Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer by Straver, M.E, Rutgers, E.J.Th, Russell, N.S, Oldenburg, H.S.A, Rodenhuis, S, Wesseling, J, Vincent, A, Peeters, M.T.F.D. Vrancken

“…Abstract Aims The purpose of this study is to analyse nodal staging and axillary response in breast cancer patients treated with neoadjuvant chemotherapy (NAC)…”
Get full text

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) by Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M.J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., Delaloge, S., Filleron, T., Gligorov, J., Gutowski, M., Jacot, W., Kirkove, C., MacGrogan, G., Michiels, S., Negreiros, I., Offersen, B.V., Penault Llorca, F., Pruneri, G., Roche, H., Russell, N.S., Schmitt, F., Servent, V., Thürlimann, B., Untch, M., van der Hage, J.A., van Tienhoven, G., Wildiers, H., Yarnold, J., Bonnetain, F., Mathoulin-Pélissier, S., Bellera, C., Dabakuyo-Yonli, T.S.

“…The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of TTE end…”
Get full text

Understanding Radiation-induced Cardiovascular Damage and Strategies for Intervention by Stewart, F.A, Seemann, I, Hoving, S, Russell, N.S

“…Abstract There is a clear association between therapeutic doses of thoracic irradiation and an increased risk of cardiovascular disease (CVD) in cancer…”
Get full text

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure by van der Noordaa, M. E. M., van Duijnhoven, F. H., Straver, M. E., Groen, E. J., Stokkel, M., Loo, C. E., Elkhuizen, P. H. M., Russell, N. S., Vrancken Peeters, M. T. F. D.

“…Background Axillary lymph node dissection (ALND) is frequently performed for node-positive (cN+) breast cancer patients. Combining positron emission…”
Get full text

Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences by Boersma, L.J., Sattler, M.G.A., Maduro, J.H., Bijker, N., Essers, M., van Gestel, C.M.J., Klaver, Y.L.B., Petoukhova, A.L., Rodrigues, M.F., Russell, N.S., van der Schaaf, A., Verhoeven, K., van Vulpen, M., Schuit, E., Langendijk, J.A.

“…Proton therapy is a radiation technique that yields less dose in normal tissues than photon therapy. In the Netherlands, proton therapy is reimbursed if the…”
Get full text

Determining the indications for post mastectomy radiotherapy: moving from 20th century clinical staging to 21st century biological criteria by Russell, N.S., Kunkler, I.H., van Tienhoven, G.

Get full text

What do patients and health care professionals view as important attributes in radiotherapy decisions? Input for a breast cancer patient decision aid by Raphael, D.B., ter Stege, J.A., Russell, N.S., Boersma, L.J., van der Weijden, T.

“…There is increased attention for shared decision making (SDM) when deciding on radiotherapy for selected patients with Stage 0–2 breast cancer. This study…”
Get full text

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) by Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M.J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., Delaloge, S., Filleron, T., Gligorov, J., Gutowski, M., Jacot, W., Kirkove, C., MacGrogan, G., Michiels, S., Negreiros, I., Offersen, B.V., Penault Llorca, F., Pruneri, G., Roche, H., Russell, N.S., Schmitt, F., Servent, V., Thürlimann, B., Untch, M., van der Hage, J.A., van Tienhoven, G., Wildiers, H., Yarnold, J., Bonnetain, F., Mathoulin-Pélissier, S., Bellera, C., Dabakuyo-Yonli, T.S.

Get full text

Nonhydrolyzable Diubiquitin Analogues Are Inhibitors of Ubiquitin Conjugation and Deconjugation by Yin, Luming, Krantz, Bryan, Russell, Nathaniel S, Deshpande, Seema, Wilkinson, Keith D

“…A series of nonhydrolyzable ubiquitin dimer analogues has been synthesized and evaluated as inhibitors of ubiquitin-dependent processes. Dimer analogues were…”
Get full text

Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition? by de Bree, E., van Coevorden, F., Peterse, J.L., Russell, N.S., Rutgers, E.J.Th

“…Aims: In view of the increasing application of breast-conserving therapy (BCT) for early breast cancer during the last decades, the number of BCT-associated…”
Get full text

Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty? by Raphael, D.B., Russell, N.S., Immink, J.M., Westhoff, P.G., Stenfert Kroese, M.C., Stam, M.R., van Maurik, L.M., van den Bongard, H.J.G.D., Maduro, J.H., Sattler, M.G.A., van der Weijden, T., Boersma, L.J.

“…Patient decision aids for oncological treatment options, provide information on the effect on recurrence rates and/or survival benefit, and on side-effects…”
Get full text

Elucidating the Role of Chest Wall Irradiation in ‘Intermediate-risk’ Breast Cancer: the MRC/EORTC SUPREMO Trial by Kunkler, I.H, Canney, P, van Tienhoven, G, Russell, N.S

Get full text

European interpretation of North American Post Mastectomy Radiotherapy Guideline Update by Kunkler, I.H, Dixon, J.M, Maclennan, M, Russell, N.S

Get full text

Radiotherapy: the last 25 years by Russell, N.S., Bartelink, H.

“…Some of the major changes in radiotherapy over the last years are reviewed in this paper. Radiotherapy has played a role in the changes in oncological practice…”
Get full text